New Medications

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Research Summaries

FDA Alert
fda
FDA Alert
FDA Approves Irinotecan Liposome For First-Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
03/04/2024
Anthony Calabro, MA
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
03/04/2024
FDA Alert
FDA Alert
FDA Alert
FDA Approves Two Medications to Treat Pediatric Patients With Type 2 Diabetes
08/10/2023
Jessica Ganga
The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.
08/10/2023
FDA Alert
Child holding stomach
FDA Alert
First Treatment for Pediatric Functional Constipation Approved by FDA
06/15/2023
Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
FDA ALERTS
FDA ALERTS
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
Conference Coverage
Conference Coverage
New and Emerging Treatments in Managing Type 2 Diabetes, Obesity
11/18/2022
Emerging treatments have improved the standard of care for managing patients with both type 2 diabetes and obesity. Carol Wysham, MD, and Deborah B. Horn, DO, MPH, discuss these new treatments and...
11/18/2022
Treatment
Treatment
FDA Approves First Treatment to Delay Stage 3 Type 1 Diabetes
11/18/2022
The recent FDA approval of the first treatment in the delay of onset type 1 diabetes provides a crucial option for certain at-risk patients.
11/18/2022
Medication
Medication
A New Drug Combination Effective in Treating Urinary Tract Infections
10/26/2022
A new drug combination was found to be more effective for treating UTIs and acute pyelonephritis compared to the current standard treatment approach.
10/26/2022
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis
FDA Approves New Medication for Treatment of ALS
10/07/2022
The recent FDA approval of a new oral treatment for patients with amyotrophic lateral sclerosis (ALS) adds another option for individuals who are diagnosed with the non-curable disease.
10/07/2022